Differential regulation of il-6 promoter activity in a human ovarian- tumor cell line transfected with various p53 mutants: Involvement of ap-1

International Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 236-242

  Asschert, Johanna G W ^a   De Vries, Elisabeth G E ^a   De Jong, Steven ^a   Withoff, Sebo ^a   Vellenga, Edo ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PROTEIN P53; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ELECTROPHORETIC MOBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE;

DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENETIC CODE; HUMANS; INTERLEUKIN-6; OVARIAN NEOPLASMS; PHENOTYPE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032965204     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990412)81:2<236::AID-IJC12>3.0.CO;2-R     Document Type: Article

References (42)

1. AKIRA, S., ISSHIKI, H., SUGITA, T., TANABE, O., KINOSHITA, S., NISHIO, Y., NAKAJIMA, T., HIRANO, T. and KISHIMOTO, T., A nuclear factor for IL-6 expression (NK-IL6) is a member of the C/EBP family. EMBO J., 9, 1897-1906 (1990).
2. ASSCHERT, J.G.W., VELLENGA, E., HOLLEMA, H., VAN DER ZEE, A.G.I. and DE VRIES, E.G.E., Expression of macrophage-colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1β, (IL-1β), interleukin-11 (IL-11), and tumor necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas. Eur. J. Cancer, 33, 2246-2251 (1997).
3. BIERHAUS, A. and 16 OTHERS, Mechanisms of the tumor-necrosis-factor-α-mediated induction of endothelial tissue factor. J. biol. Chem., 270, 26419-26432 (1995).
4. BOENTE, M.P., HURTEAU, J., RODRIGUEZ, G.C., BAST, R.C. JR. and BERCHUCK, A., The biology of ovarian cancer. Curr. Opin. Oncol., 5, 900-907 (1993).
5. CHO, Y., GORINA, S., JEFFREY, P.D. and PAVLETICH, N.P., Crystal structure of a p53-tumor-suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
6. DOKTER, W.H.A., TUYT, L., SIERDSEMA, S.J., ESSELINK, M.T. and VELLENGA, E., The spontaneous expression of interleukin-1β and interleukin-6 is associated with spontaneous expression of AP-1 and NF-κB transcription factor in acute myeloblastic leukemia cells. Leukemia, 9, 425-432 (1995).
7. GINSBERG, D., MECHTA, F., YANIV, M. and OREN, M., Wild-type p53 can down-modulate the activity of various promoters. Proc. nat. Acad. Sci. (Wash.), 88, 9979-9983 (1991).
8. HSU, W., KERPOLLA, T.K., CURRAN, T. and CHEN-KIANG, S., Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol. cell. Biol., 14, 268-276 (1994).
9. HUDZIAK, R.M., LEWIS, G.D., SHALABY, M.R., EESSALU, T.E., AGGARWAL, B.B., ULLRICH, A. and SHEPARD, H.M., Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor-necrosis factor α in NIH 3T3 cells. Proc. nat. Acad. Sci. (Wash.). 85, 5102-5106 (1988).
10. JANASWAMI, P.M., KALVAKOLANU, D.V., ZHANG, Y. and SEN, G.C., Transcriptional repression of the interleukin-6 gene by adenoviral protein EIA. J. biol. Chem., 267, 24886-24891 (1992).
11. KARIN, M., The regulation of AP-1 activity by mitogen-activated protein kinases. J. biol. Chem., 270, 16483-16486 (1995).
12. KAWAMURA, M., YAMASHITA, T., SEGAWA, K., KANEUCHI, M., SHINDOH, M. and FUJINAGA, K., The 273 rd mutants of p53 show growth modulation activities not correlated with specific transactivation activity. Oncogene, 12, 2361-2367 (1996).
13. KOHLER, M.F., KERNS, B.-J.M., HUMPHREY, P.A., MARKS, J.R., BAST, R.C. and BERCHUCK, A., Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet. Gynecol., 81, 643-650 (1993).
14. LIBERMANN, T.A. and BALTIMORE, D., Activation of interleukin-6-gene expression through the NF-κB transcription factor. Mol. cell. Biol., 10, 2327-2334 (1990).
15. LICHTENSTEIN, A., GERA, J.F. ANDREWS, J., BERENSON, J. and WARE, C.F., Inhibitors of ADP-ribose polymerase decrease resistance of HER2/neuexpressing cancer cells to the cytotoxic effects of tumor necrosis factor. J. Immunol., 146, 2052-2058 (1990).
16. LU, G., BEUERMAN, R.W., ZHAO, S., SUN, G., NGUYEN, D.H., MA, S. and KLINE, D.G., Tumor necrosis factor-alpha and interleukin-1 induce activation of MAP kinase and SAP kinase in human neuroma fibroblasts. Neurochem. Int., 30, 401-410 (1997).
17. MARGULIES, L. and SEGHAL, P.B., Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBPβ (NF-IL6) activity by p53 species. J. biol. Chem., 268, 15096-15100 (1993).
18. MARKS, J.R., DAVIDOFF, A.M., KERNS, B.J., HUMPHREYS, P.A., PENCE, J.C., DODGE, R.K., CLARKE-PEARSON, D.L., IGLEHART, R.C., BAST, R.C. JR. and BERCHUCK, A., Over-expression and mutation of p53 in epithelial ovarian cancer. Cancer Res., 51, 2979-2984 (1991).
19. MORIGUCHI, T., TOYOSHIMA, F., MASUYAMA, N., HANAFUSA, H., GOTOH, Y. and NISHIDA, E., A novel SAPK/JNK kinase, MKK7, stimulated by TNF-α and cellular stresses. EMBO J., 16, 7045-7053 (1997).
20. NATOLI, G., COSTANZO, A., MORETTI, F., FULCO, M., BALSANO, C. and LEVRERO, M., Tumor necrosis factor(TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB NF-κB.-inducing kinase requirement for activation of activating protein 1 and NF kappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J. biol. Chem., 272, 26079-26082 (1997).
21. POULOS, J.E., WEBER, J.D., BELEZZO, J.M., DI BISCEGLIE, A.M., BRITTON, R.S., BACON, B.R. and BALDASSARE, J.J., Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transient gene expression in rat hepatic stellate cells. Amer. J. Physiol., 273, 804-811 (1997).
22. RAY, A., SASSONNE-CORSI, P. and SEGHAL, P., A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol. cell. Biol., 9, 5537-5547 (1989).
23. REINHARD, C., SHAMOON, B., SHYAMALA, V. and WILLIAMS, L.T., Tumor-necrosis-factor-alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J., 16, 1080-1092 (1997).
24. ROGAN, A.M., HAMILTON, T.C., YOUNG, R.C., KLECKER, R.W. and OZOLS, R.F., Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science, 65, 994-996 (1984).
25. ROLLEY, N., BUTCHER, S. and MILNER, J., Specific DNA binding by different classes of human p53 mutants. Oncagene, 11, 763-770 (1995).
26. RUNNEBAUM, I.E., TONG, X.W., MOHUS, V.J., KIEBACK, D.G., ROSENTHAL, H.E. and KREIENBERG, R., p51 mutant His175 identified in a newly established Fallopian-tube-cardnoma cell line secreting IL-6. FEBS Lett., 353, 29-32 (1994).
27. RYSECK, R.P. and BRAVO, R., c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene, 6, 533-542 (1991).
28. SANCHEZ, I., HUGHES, R.T., MAYER, B.J., YEE, K., WOODGETT, J.R., AVRUCH, J., KYRIAKIS, J.M. and ZON, L.I., Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (Lond.). 372, 794-798 (1994).
29. SANTHANAM, U., RAY, A. and SEGHAL, P.B., Repression of the interleukin-6 promoter by p53 and the retinoblastoma-susceptible gene product. Proc. nat. Acad. Sci. (Wash.), 88, 7605-7609 (1991).
30. SCHREIBER, E., MATTHIAS, P., MÜLLER, M.M. and SCHAFFNER, W., Rapid detection of octamer-binding proteins with "mini extracts", prepared from a small number of cells. Nucleic Acids Res., 17, 6419 (1989).
31. SHIMIZU, H., MITOMO, K., WATANABE, T., OKAMOTO, S. and YAMAMOTO, K., Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. cell. Biol., 10, 561-568 (1990).
32. SLEIJFER, S., DE JONG, S., WITHOFF, S. and MULDER, N.H., Increased sensitivity to tumor necrosis factor-α in a human tumor cell line transfected with mutated p53. Proc. Amer. Ass. Cancer Res., 39, abstract 197 (1998).
33. STEIN, B., BALDWIN, A.S. JR., BALLARD, D.W., GREENE, W.C., ANGEL, P. and HERRLICH, P., Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J., 12, 1879-3891 (1993).
34. SUZUKI, T., UKUNO, H., YOSHIDA, T., ENDO, T., NISHINA, H. and IHA, H., Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res., 19, 5537-5542 (1991).
35. VAN DEN BERGHE, W., PLAISANCE, S., BOONE, E., DE BOSSCHER, K., SCHMITZ, M.L., FIERS, W. and HAEGEMAN, G., p38 and extracellular-signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. biol. Chem., 6, 3285-3290 (1998).
36. VAN DER ZEE, A.G.J., HOLLEMA, H., SUURMEUER, A.J.H., KRANS, M., SLUITER, W.J., WILLEMSE, P.H.B., AALDERS, J.G. and DE VRIES, E.G.E., The value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2 and p53 as prognostic factors in ovarian carcinomas. J. clin. Oncol., 13, 70-78 (1995).
37. VAN WAARDENBURG, R.C.A.M., DE JONG, S., WITHOFF, S., DE VRIES, E.G.E. and MULDER, N.H., Effects of wild-type or mutant p53 overexpression in a wild-type p53 ovarian-tumor cell line. Proc. Amer. Ass. Cancer Res., 38, abstract 1830 (1997).
38. WATSON, J.M., SENSINTAFFAR, J.L., BEREK, J.S. and MARTINEZ-MAZA, O., Constitutive production of interleukin-6 by ovarian carcinoma cell lines and by primary ovarian tumor cultures. Cancer Res., 50, 6959-6965 (1990).
39. WINSTON, B.W., CHAN, E.D., JOHNSON, G.L. and RICHES, D.W., Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages. J. Immunol. 159, 4491-4497 (1997).
40. WU, S., BOYER, C.M., WHITACKER, R.S., BERCHUCK, A., WIENER, J.R., WEINBERG, J.B. and BAST, R.C. JR., Tumor necrosis factor a as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor-necrosis factor-α production. Cancer Res., 53, 1939-1944 (1993).
41. WYATT, T.A., ITO, H., VEYS, T.J. and SPURZEM, J.R., Stimulation of protein kinase-C activity by tumor necrosis factor-alpha in bovine bronchial epithelial cells. Amer. J. Physiol., 273, 1007-1012 (1997).
42. ZHANG, P., MILLER, B.S., ROSENZWEIG, S.A. and BHAT, N.R., Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J. Neurosci. Res., 46, 114-121 (1996).